Autopsy report · NCT04915404

Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Business decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 9 months before it started.
Ran for about 1 year 1 month before it stopped.
5 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: WPD Pharmaceuticals Sp. z o.o.
Sponsor type: Industry
Conditions: Recurrent Glioblastoma Multiforme
Interventions: Berubicin Hydrochloride
Participants: 5
Sites: 2
Countries: Poland

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.